{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:56:36Z","timestamp":1783436196626,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Varicella-zoster virus (VZV) is a highly contagious agent of varicella and herpes zoster. Varicella can be lethal to immunocompromised patients, babies, HIV patients and other adults with impaired immunity. Serological evaluation of immunity to VZV will help determine which individuals are susceptible and evaluate vaccine effectiveness. A collection of 110 monoclonal antibodies (mAbs) were obtained by immunization of mice with membrane proteins or cell-free virus. The mAbs were well characterized and a competitive sandwich ELISA (capture mAb: 8H6; labelling mAb: 1B11) was established to determine neutralizing antibodies in human serum with reference to the FAMA test. A total of 920 human sera were evaluated. The competitive sandwich ELISA showed a sensitivity of 95.6%, specificity of 99.77% and coincidence of 97.61% compared with the fluorescent-antibody-to-membrane-antigen (FAMA) test. The capture mAb 8H6 was characterized as a specific mAb for VZV ORF9, a membrane-associated tegument protein that interacts with glycoprotein E (gE), glycoprotein B (gB) and glycoprotein C (gC). The labelling mAb 1B11 was characterized as a complement-dependent neutralizing mAb specific for the immune-dominant epitope located on gE, not on other VZV glycoproteins. The established competitive sandwich ELISA could be used as a rapid and high-throughput method for evaluating immunity to VZV.<\/jats:p>","DOI":"10.1038\/srep20577","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T09:50:35Z","timestamp":1454925035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay"],"prefix":"10.1038","volume":"6","author":[{"given":"Jian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"BFsrep20577_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet, M. et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. Can Med Assoc J. 182, 1731\u20131736 (2010).","journal-title":"Can Med Assoc J."},{"key":"BFsrep20577_CR2","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","volume":"30","author":"N Dendouga","year":"2012","unstructured":"Dendouga, N., Fochesato, M., Lockman, L., Mossman, S. & Giannini, S. L. Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. Vaccine. 30, 3126\u20133135 (2012).","journal-title":"Vaccine."},{"key":"BFsrep20577_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jocn.2006.09.001","volume":"14","author":"K Sawanyawisuth","year":"2007","unstructured":"Sawanyawisuth, K., Phuttharak, W., Tiamkao, S. & Boonpila, A. MRI findings in acute disseminated encephalomyelitis following varicella infection in an adult. J Clin Neurosci. 14, 1230\u20131233 (2007).","journal-title":"J Clin Neurosci."},{"key":"BFsrep20577_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/0974-620X.149874","volume":"8","author":"J Jain","year":"2015","unstructured":"Jain, J., Thatte, S. & Singhai, P. Periorbital varicella gangrenosa: A rare complication of chicken pox. Oman J Ophthalmol. 8, 64\u201366 (2015).","journal-title":"Oman J Ophthalmol."},{"key":"BFsrep20577_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1212\/01.wnl.0000439052.05262.1d","volume":"81","author":"B Bourre","year":"2013","unstructured":"Bourre, B., Lefaucheur, R., Ahtoy, P., Travers, F. & Fetter, D. Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Neurology. 81, 1966\u20131967 (2013).","journal-title":"Neurology."},{"key":"BFsrep20577_CR6","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1086\/522156","volume":"197","author":"D Guris","year":"2008","unstructured":"Guris, D. et al. Changing varicella epidemiology in active surveillance sites\u2013United States, 1995\u20132005. J Infect Dis. 197 Suppl 2, S71\u201375 (2008).","journal-title":"J Infect Dis."},{"key":"BFsrep20577_CR7","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman, M. N. et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 352, 2271\u20132284 (2005).","journal-title":"N Engl J Med."},{"key":"BFsrep20577_CR8","first-page":"359","volume":"342","author":"AA Gershon","year":"2010","unstructured":"Gershon, A. A. & Gershon, M. D. Perspectives on vaccines against varicella-zoster virus infections. Curr Top Microbiol Immunol. 342, 359\u2013372 (2010).","journal-title":"Curr Top Microbiol Immunol."},{"key":"BFsrep20577_CR9","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1128\/JCM.00719-06","volume":"44","author":"A Sauerbrei","year":"2006","unstructured":"Sauerbrei, A. & Wutzler, P. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol. 44, 3094\u20133097 (2006).","journal-title":"J Clin Microbiol."},{"key":"BFsrep20577_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jviromet.2004.02.012","volume":"119","author":"A Sauerbrei","year":"2004","unstructured":"Sauerbrei, A., Farber, I., Brandstadt, A., Schacke, M. & Wutzler, P. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. J Virol Methods. 119, 25\u201330 (2004).","journal-title":"J Virol Methods."},{"key":"BFsrep20577_CR11","first-page":"23","volume":"27","author":"K Baba","year":"1984","unstructured":"Baba, K. et al. A simplified immunofluorescence technique for antibody to varicella-zoster membrane antigen (FAMA). Biken J. 27, 23\u201329 (1984).","journal-title":"Biken J."},{"key":"BFsrep20577_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/infdis\/130.6.669","volume":"130","author":"V Williams","year":"1974","unstructured":"Williams, V., Gershon, A. & Brunell, P. A. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis. 130, 669\u2013672 (1974).","journal-title":"J Infect Dis."},{"key":"BFsrep20577_CR13","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/jmv.20754","volume":"78","author":"O Hammond","year":"2006","unstructured":"Hammond, O. et al. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. J Med Virol. 78, 1679\u20131687 (2006).","journal-title":"J Med Virol."},{"key":"BFsrep20577_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/infdis\/148.3.472","volume":"148","author":"Z Shehab","year":"1983","unstructured":"Shehab, Z. & Brunell, P. A. Enzyme-linked immunosorbent assay for susceptibility to varicella. J Infect Dis. 148, 472\u2013476 (1983).","journal-title":"J Infect Dis."},{"key":"BFsrep20577_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jmv.1890320310","volume":"32","author":"EH Wasmuth","year":"1990","unstructured":"Wasmuth, E. H. & Miller, W. J. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol. 32, 189\u2013193 (1990).","journal-title":"J Med Virol."},{"key":"BFsrep20577_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0092-1157(86)90023-5","volume":"14","author":"R Winsnes","year":"1986","unstructured":"Winsnes, R. & Wiger, D. The potency determination of human varicella-zoster immunoglobulin by enzyme-linked immunosorbent assay, complement-fixation test and indirect fluorescent antibody tests. J Biol Stand. 14, 351\u2013361 (1986).","journal-title":"J Biol Stand."},{"key":"BFsrep20577_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0928-0197(94)90051-5","volume":"2","author":"AA Gershon","year":"1994","unstructured":"Gershon, A. A., Larussa, P. & Steinberg, S. Detection of antibodies to varicella-zoster virus using a latex agglutination assay. Clin Diagn Virol. 2, 271\u2013277 (1994).","journal-title":"Clin Diagn Virol."},{"key":"BFsrep20577_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/CVI.13.2.214-218.2006","volume":"13","author":"PA Maple","year":"2006","unstructured":"Maple, P. A. et al. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin Vaccine Immunol. 13, 214\u2013218 (2006).","journal-title":"Clin Vaccine Immunol."},{"key":"BFsrep20577_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4014\/jmb.1408.08048","volume":"25","author":"R Park","year":"2015","unstructured":"Park, R. et al. Measurement of antibodies to Varicella-zoster virus using a virus-free fluorescent-antibody-to-membrane antigen (FAMA) test. J Microbiol Biotechnol. 25, 268\u2013273 (2015).","journal-title":"J Microbiol Biotechnol."},{"key":"BFsrep20577_CR20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1128\/CVI.05130-11","volume":"18","author":"MM Lafer","year":"2011","unstructured":"Lafer, M. M. et al. Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus. Clin Vaccine Immunol. 18, 1194\u20131197 (2011).","journal-title":"Clin Vaccine Immunol."},{"key":"BFsrep20577_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1128\/CVI.00250-14","volume":"21","author":"JI Cohen","year":"2014","unstructured":"Cohen, J. I. et al. Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay. Clin Vaccine Immunol. 21, 1288\u20131291 (2014).","journal-title":"Clin Vaccine Immunol."},{"key":"BFsrep20577_CR22","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1086\/529043","volume":"197","author":"DE Michalik","year":"2008","unstructured":"Michalik, D. E. et al. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 197, 944\u2013949 (2008).","journal-title":"J Infect Dis."},{"key":"BFsrep20577_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1542\/peds.72.3.291","volume":"72","author":"Y Asano","year":"1983","unstructured":"Asano, Y. et al. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics. 72, 291\u2013294 (1983).","journal-title":"Pediatrics."},{"key":"BFsrep20577_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01315277","volume":"75","author":"Y Asano","year":"1983","unstructured":"Asano, Y., Albrecht, P., Vujcic, L. K., Quinnan, G. V., Jr. & Takahashi, M. Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test. Arch Virol. 75, 225\u2013228 (1983).","journal-title":"Arch Virol."},{"key":"BFsrep20577_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jviromet.2010.09.023","volume":"171","author":"L Huang","year":"2011","unstructured":"Huang, L., Lu, Y., Wei, Y., Guo, L. & Liu, C. Development of a blocking ELISA for detection of serum neutralizing antibodies against porcine circovirus type 2. J Virol Methods. 171, 26\u201333 (2011).","journal-title":"J Virol Methods."},{"key":"BFsrep20577_CR26","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.vaccine.2009.01.126","volume":"27","author":"S Zhang","year":"2009","unstructured":"Zhang, S., Liu, Y., Zhang, F. & Hu, R. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs. Vaccine. 27, 2108\u20132113 (2009).","journal-title":"Vaccine."},{"key":"BFsrep20577_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ijid.2006.09.013","volume":"11","author":"K Muhamuda","year":"2007","unstructured":"Muhamuda, K., Madhusudana, S. N. & Ravi, V. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans. Int J Infect Dis. 11, 441\u2013445 (2007).","journal-title":"Int J Infect Dis."},{"key":"BFsrep20577_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1006\/viro.1997.8625","volume":"233","author":"H Kimura","year":"1997","unstructured":"Kimura, H., Straus, S. E. & Williams, R. K. Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. Virology. 233, 382\u2013391 (1997).","journal-title":"Virology."},{"key":"BFsrep20577_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1006\/viro.1995.0064","volume":"214","author":"WJ Fowler","year":"1995","unstructured":"Fowler, W. J. et al. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus. Virology. 214, 531\u2013540 (1995).","journal-title":"Virology."},{"key":"BFsrep20577_CR30","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1128\/JVI.00303-08","volume":"82","author":"X Che","year":"2008","unstructured":"Che, X. et al. Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. J Virol. 82, 5825\u20135834 (2008).","journal-title":"J Virol."},{"key":"BFsrep20577_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02121130","volume":"166","author":"MH Wolff","year":"1978","unstructured":"Wolff, M. H. The proteins of varicella-zoster-virus. Med Microbiol Immunol. 166, 21\u201328 (1978).","journal-title":"Med Microbiol Immunol."},{"key":"BFsrep20577_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM196208232670801","volume":"267","author":"AH Ross","year":"1962","unstructured":"Ross, A. H. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med. 267, 369\u2013376 (1962).","journal-title":"N Engl J Med."},{"key":"BFsrep20577_CR33","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/S0140-6736(94)92943-2","volume":"343","author":"G Enders","year":"1994","unstructured":"Enders, G., Miller, E., Cradock-Watson, J., Bolley, I. & Ridehalgh, M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 343, 1548\u20131551 (1994).","journal-title":"Lancet."},{"key":"BFsrep20577_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0166-0934(86)90048-0","volume":"14","author":"PM Keller","year":"1986","unstructured":"Keller, P. M., Lonergan, K., Neff, B. J., Morton, D. A. & Ellis, R. W. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies. J Virol Methods. 14, 177\u2013188 (1986).","journal-title":"J Virol Methods."},{"key":"BFsrep20577_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0264-410X(91)90266-9","volume":"9","author":"PJ Provost","year":"1991","unstructured":"Provost, P. J. et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine. 9, 111\u2013116 (1991).","journal-title":"Vaccine."},{"key":"BFsrep20577_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/jvi.52.1.293-297.1984","volume":"52","author":"PM Keller","year":"1984","unstructured":"Keller, P. M., Neff, B. J. & Ellis, R. W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol. 52, 293\u2013297 (1984).","journal-title":"J Virol."},{"key":"BFsrep20577_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0042-6822(85)90201-6","volume":"145","author":"CM Edson","year":"1985","unstructured":"Edson, C. M. et al. Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material. Virology. 145, 62\u201371 (1985).","journal-title":"Virology."},{"key":"BFsrep20577_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0042-6822(86)90124-8","volume":"149","author":"EA Montalvo","year":"1986","unstructured":"Montalvo, E. A. & Grose, C. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology. 149, 230\u2013241 (1986).","journal-title":"Virology."},{"key":"BFsrep20577_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1128\/iai.40.1.381-388.1983","volume":"40","author":"C Grose","year":"1983","unstructured":"Grose, C., Edwards, D. P., Friedrichs, W. E., Weigle, K. A. & McGuire, W. L. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun. 40, 381\u2013388 (1983).","journal-title":"Infect Immun."},{"key":"BFsrep20577_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1128\/jvi.57.3.1195-1197.1986","volume":"57","author":"AJ Davison","year":"1986","unstructured":"Davison, A. J. et al. New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol. 57, 1195\u20131197 (1986).","journal-title":"J Virol."},{"key":"BFsrep20577_CR41","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1007\/s00253-015-6605-2","volume":"99","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine. Appl Microbiol Biotechnol. 99, 4545\u20134553 (2015).","journal-title":"Appl Microbiol Biotechnol."},{"key":"BFsrep20577_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2144\/97222rr02","volume":"22","author":"C Hatfield","year":"1997","unstructured":"Hatfield, C., Duus, K. M., Chen, J., Jones, D. H. & Grose, C. Epitope mapping and tagging by recombination PCR mutagenesis. Biotechniques. 22, 332\u2013337 (1997).","journal-title":"Biotechniques."},{"key":"BFsrep20577_CR43","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1128\/JVI.77.8.4888-4898.2003","volume":"77","author":"MJ Brignati","year":"2003","unstructured":"Brignati, M. J., Loomis, J. S., Wills, J. W. & Courtney, R. J. Membrane association of VP22, a herpes simplex virus type 1 tegument protein. J Virol. 77, 4888\u20134898 (2003).","journal-title":"J Virol."},{"key":"BFsrep20577_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/bbrc.2002.6450","volume":"291","author":"M Lundberg","year":"2002","unstructured":"Lundberg, M. & Johansson, M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem Biophys Res Commun. 291, 367\u2013371 (2002).","journal-title":"Biochem Biophys Res Commun."},{"key":"BFsrep20577_CR45","first-page":"341","volume":"342","author":"A Weinberg","year":"2010","unstructured":"Weinberg, A. & Levin, M. J. VZV T cell-mediated immunity. Curr Top Microbiol Immunol. 342, 341\u2013357 (2010).","journal-title":"Curr Top Microbiol Immunol."},{"key":"BFsrep20577_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jviromet.2014.01.014","volume":"200C","author":"L Chen","year":"2014","unstructured":"Chen, L. et al. Development of a varicella-zoster virus neutralization assay using a glycoprotein K antibody enzyme-linked immunosorbent spot assay. J Virol Methods. 200C, 10\u201314 (2014).","journal-title":"J Virol Methods."},{"key":"BFsrep20577_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0166-0934(98)00176-1","volume":"79","author":"K Hawrami","year":"1999","unstructured":"Hawrami, K. & Breuer, J. Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus. J Virol Methods. 79, 33\u201340 (1999).","journal-title":"J Virol Methods."},{"key":"BFsrep20577_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/15321819508013570","volume":"16","author":"VC Tsang","year":"1995","unstructured":"Tsang, V. C., Greene, R. M. & Pilcher, J. B. Optimization of the covalent conjugating procedure (NaIO4) of horseradish peroxidase to antibodies for use in enzyme-linked immunosorbent assay. J Immunoassay. 16, 395\u2013418 (1995).","journal-title":"J Immunoassay."},{"key":"BFsrep20577_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/infdis\/136.4.519","volume":"136","author":"JA Zaia","year":"1977","unstructured":"Zaia, J. A. & Oxman, M. N. Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J Infect Dis. 136, 519\u2013530 (1977).","journal-title":"J Infect Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep20577","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T13:23:20Z","timestamp":1672838600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep20577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,26]]}},"alternative-id":["BFsrep20577"],"URL":"https:\/\/doi.org\/10.1038\/srep20577","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,8]]},"assertion":[{"value":"29 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20577"}}